Uniting disciplines against antimicrobial resistance (AMR): highlights from a multidisciplinary inaugural AMR summit
- PMID: 40666138
- PMCID: PMC12260250
- DOI: 10.1017/ash.2025.10039
Uniting disciplines against antimicrobial resistance (AMR): highlights from a multidisciplinary inaugural AMR summit
Erratum in
-
Erratum: Uniting disciplines against antimicrobial resistance (AMR): highlights from a multidisciplinary inaugural AMR summit - ERRATUM.Antimicrob Steward Healthc Epidemiol. 2025 Sep 16;5(1):e219. doi: 10.1017/ash.2025.10099. eCollection 2025. Antimicrob Steward Healthc Epidemiol. 2025. PMID: 40989664 Free PMC article.
Abstract
Antimicrobial resistance (AMR) poses a significant global health threat, projected to cause 10 million deaths annually by 2050. Addressing AMR requires a coordinated, multidisciplinary approach encompassing infectious disease (ID) clinicians, pharmacists, microbiologists, infection preventionists, and policymakers. The inaugural AMR Summit, hosted by bioMérieux in collaboration with Tampa General Hospital and the University of South Florida Morsani College of Medicine in November 2024, convened experts from various fields to explore innovative strategies for combating AMR. Key topics discussed included the role of multidisciplinary teams in antimicrobial stewardship programs, advancements in rapid diagnostic tests and antimicrobial susceptibility testing, the application of implementation science in AMR, and the integration of next-generation sequencing in ID diagnostics. The summit underscored the importance of diagnostic innovation, interdisciplinary collaboration, policy, advocacy, and public engagement in advancing efforts against AMR.
© The Author(s) 2025.
Conflict of interest statement
AMP, MW, and BKH are paid employees of bioMérieux. DTN is a consultant for bioMérieux. BAR, RT, HS, ARA, and SS work at medical facilities that have been designated as Centers of Excellence (COE) by bioMérieux but receive no financial compensation for COE-related projects; they have no relevant COI to disclose. DM has no relevant COI to disclose.
Figures
References
-
- O’Neil J. Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance. 2016;
-
- Peri AM, Chatfield MD, Ling W, Furuya-Kanamori L, Harris PNA, Paterson DL. Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: what is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis. Clin Infect Dis 2024;79:502–515. doi: 10.1093/cid/ciae234 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources